Ascendis Pharma A (ASND) Return on Invested Capital (2021 - 2026)

Ascendis Pharma A has disclosed Return on Invested Capital across 6 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Invested Capital for Q1 2026 came in at 0.0%, down 520.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (down 520.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q1 2026 at Ascendis Pharma A, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 5.55% in Q4 2024 to a low of 0.02% in Q2 2023.
• The 5-year median for Return on Invested Capital is 0.01% (2024), against an average of 1.22%.
• Across the five-year window, Return on Invested Capital soared 556 bps in 2024 and slumped 555 bps in 2025, its largest moves.
• Ascendis Pharma A's Return on Invested Capital stood at 0.01% in 2022, then decreased by 13 bps to 0.01% in 2023, then jumped by 57830 bps to 5.55% in 2024, then tumbled by 100 bps to 0.0% in 2025, then surged by 114 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 4.88% (Q3 2025), per Business Quant data.